Upgrade to SI Premium - Free Trial

BMO Capital Starts Alnylam Pharmaceuticals (ALNY) at Outperform

August 18, 2026 4:13 PM
(Updated - August 19, 2026 5:29 AM EDT)

BMO Capital analyst David Lebowitz initiates coverage on Alnylam Pharmaceuticals (NASDAQ ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments New Coverage